Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleEruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists.AuthorsPagliarello, Calogero; Girardelli, Carlo Renè; Stanganelli, IgnazioAbstractBecause of its higher level of safety compared to its parent medicine, thalidomide, lenalidomide (L) is chosen for the treatment of multiple myeloma. We report a patient who, within a month of using L, developed more than 10 basal cell carcinomas.SubjectsBASAL cell carcinoma; LENALIDOMIDE; DERMATOLOGISTS; MULTIPLE myeloma; THALIDOMIDEPublicationDermatology Reports, 2023, Vol 15, Issue 1, p1ISSN2036-7406Publication typeCase StudyDOI10.4081/dr.2022.9534